Orifarm is planning to expand and synergise

Orifarm says it is “investing heavily” in the firm’s generics division to ensure future growth in the business, including an expansion of its laboratory in Skælskør, Denmark. The location in Skælskør houses Viminco, which Orifarm acquired in 2015 “as part of an increased strategic focus on retail medicine and niche products”, and employs approximately 100 staff.